Immune cells injected into brain show promise against deadly cancer
NCT ID NCT03383978
First seen May 01, 2026 · Last updated Jun 18, 2026 · Updated 7 times
Summary
This early-phase study tests a new treatment for people with a recurring type of brain cancer called glioblastoma. The treatment uses specially designed immune cells (NK-92/5.28.z) that are injected directly into the brain to attack cancer cells. The main goals are to check safety, find the best dose, and see if the treatment can shrink tumors or slow the disease. Some participants will also receive an additional immunotherapy drug.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Johann W. Goethe University Hospital, Department of Neurosurgery
RECRUITINGFrankfurt, 60590, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Johann W. Goethe University Hospital, Senckenberg Institute of Neurooncology
RECRUITINGFrankfurt, 60590, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Neurochirurgische Klinik, Universitätsklinikum Heidelberg
RECRUITINGHeidelberg, Baden-Wurttemberg, 69120, Germany
Contact Email: •••••@•••••
-
Neurochirurgische Klinik, Universitätsmedizin Mainz
RECRUITINGMainz, Rhineland-Palatinate, 55131, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Neurochirurgische Klinik, Universitätsmedizin Mannheim
RECRUITINGMannheim, Baden-Wurttemberg, 68167, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.